Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR-tyrosine kinase inhibitor treatment response
详细信息 查看全文
- 作者：Ha Young Park ; Hyung Joo Oh ; Ki-Hyun Kim ; Tae-Ok Kim ; Cheol-Kyu Park ; Hong-Jun Shin ; Jung-Hwan Lim ; Yong-Soo Kwon ; In-Jae Oh ; Yu-Il Kim ; Sung-Chul Lim ; Young-Chul Kim and Yoo-Duk Choi
- 刊名：Thoracic Cancer
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：7
- 期：6
- 页码：639-647
- 全文大小：502K
- ISSN：1759-7714
文摘
Epidermal growth factor receptor (EGFR) gene mutation is a reliable predictive factor for response to EGFR-tyrosine kinase inhibitors (TKIs). The quantified EGFR value may also predict response and survival within an EGFR mutated group.